- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02980588
The Effects of SGC on Glucose Control in Critically Ill Patients With Sepsis
Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Sepsis in ICU
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design: The study was conducted as a single-centre, open randomized controlled, parallel trial.
Study population: Adult general ICU patients with sepsis and assumed to require at least 3 days of intensive care were recruited. Patients fulfilling the inclusion criterion of glucose≥9.0 mmol/L were randomly assigned using serially numbered to either the intervention group (BG control by SGC) or the control group (conventional empiric BG management). The both group aim to establish the BG levels 5.8-8.9mmol/L.
Study protocol: BG measurements were performed using glucometer to test the fingertip capillary blood sample for the BG levels. As for patients with shock or required vasopressor, arterial BG was sampled to measure through the glucometer. Insulin was infused intravenously applying the standard perfusor of the ICU. Average glucose, glucose variability, SOFA score, APACHE II score, and HLA-DR were recorded. All trial-related activities were carried out until the end of the patient's ICU stay, or for a period of 72 hours. Meanwhile, enteral and parenteral nutrition was administrated to patients according to their condition.
Statistical analysis was performed on an intention-to-treat basis. The percentage of values in the target range (5.8-8.9mmol/L) was defined as primary end point for the assessment of glucose control. Data are reported as mean±SD values if not otherwise indicated. Data analysis was performed using SPSS19.0.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Min Mo, Doctor
- Phone Number: 13914719904
- Email: momin_2002@163.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admitted to the ICU
- At least one BG measurement 9.0mmol/L or higher
- Expected to stay in ICU ≥3 days;
- critically ill patients with sepsis
- SOFA score≤2
Exclusion Criteria:
- Aged < 18 years;
- Admitted because of diabetic ketoacidosis or nonketotic hyperosmolar state
- Pregnant
- In a state in which death was perceived as imminent
- Without written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: conventional empirical glycemic control
the patients' blood glucose is controlled by physician according to their experience through insulin subcutaneous injection or insulin continuous infusion whose dosage is determinated by the physician.
|
the patients' blood glucose is controlled by SGC system through insulin continuous infusion whose dosage is determinated by SGC
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
glucose variability
Time Frame: up to 3days
|
mean blood glucose, standard deviation (SD) for the mean glucose,minimum and maximum glucose levels
|
up to 3days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HLADr
Time Frame: up to 3days
|
up to 3days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Zhongda-ICU-SGC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia
-
Mayo ClinicCompletedHospital Hyperglycemia | Post-transplant HyperglycemiaUnited States
-
Zealand University HospitalNot yet recruitingStress Hyperglycemia | Postoperative Hyperglycemia
-
University of CopenhagenUnknownSurgery--Complications | Hyperglycemia Stress | Hyperglycemia Steroid-inducedDenmark
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
University Hospital, Gentofte, CopenhagenCompletedPancreatectomy; HyperglycemiaDenmark
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
National University, SingaporeNational University Health System, SingaporeCompletedPostprandial HyperglycemiaSingapore
-
Coordinación de Investigación en Salud, MexicoUnknownStress HyperglycemiaMexico
-
University of Eastern FinlandCompletedPostprandial HyperglycemiaFinland
-
University of LeedsCompletedHyperglycemia, PostprandialUnited Kingdom
Clinical Trials on SGC directed glycemic control
-
Peking Union Medical College HospitalUnknownHyperglycemia | Critical Illness | Respiratory FailureChina
-
The University of Texas Health Science Center,...National Institutes of Health (NIH)Terminated
-
Ramon OliveiraTerminatedLiver Transplantation | Surgical Wound InfectionBrazil
-
Temple UniversityMedical University of South Carolina; National Institute of Neurological Disorders... and other collaboratorsCompletedHyperglycemia | Stroke | Procoagulation MarkersUnited States
-
University of California, DavisCompleted
-
Poissy-Saint Germain HospitalUnknownHyperglycemia | Critically Ill PatientsFrance
-
Université de SherbrookeTerminatedGestational Diabetes MellitusCanada
-
Taipei Veterans General Hospital, TaiwanUnknownType 2 DiabetesTaiwan
-
University of ManitobaCompleted